Prakash Kumar Sahoo

Prakash Kumar Sahoo


Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2024 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
PRP. Ratna
P. Ratna
ASAbhinav Sinha
Abhinav Sinha
SPSanghamitra Pati
Sanghamitra Pati
PSPrakash Kumar Sahoo
Prakash Kumar Sahoo
Background: Lymphatic filariasis (LF) persists as a public health problem in India. Despite more than ten rounds of mass drug administration (MDA), LF continues to be endemic in the Dhenkanal district of Odisha. Hence, we assessed the coverage and compliance of the MDA program and explored the factors affecting it in the Dhenkanal district.Methods: An explanatory mixed-method study was conducted, wherein for the quantitative survey, 552 participants aged 2 years and above were recruited following a multistage cluster random sampling during February 2022. In-depth interviews were conducted among purposively selected key stakeholders and program implementers. Descriptive statistics were used to report coverage and compliance, along with a 95% confidence interval. Qualitative data were analyzed using a thematic approach.Results: We observed coverage of 99.28% and compliance of 85.87% for MDA drugs. Supervised drug administration proved to be a major pillar in increasing compliance. There was difficulty in administering drugs in urban areas due to gated societies, the absence of individuals during the day, and the perspective toward healthcare providers. Participants reported a lack of confidence in drug distributors and a fear of side effects as major causes for non-compliance.Conclusion: There is a need to strengthen MDA, especially in urban areas. An urban-specific strategy, along with surveillance, behavioral change communication, and the involvement of multi-disciplinary teams, is required.

3 September 2015 in Gut Pathogens
Verified
Journal Article
Open access
PDF file
SJSangeeta Jaiswal
Sangeeta Jaiswal
NPNiladri Bhusan Pati
Niladri Bhusan Pati
MDManupriyam Dubey
Manupriyam Dubey
CPChandrashekhar Padhi
Chandrashekhar Padhi
PSPrakash Kumar Sahoo
Prakash Kumar Sahoo
Mrutyunjay SuarMrutyunjay Suar
Mrutyunjay Suar
Salmonella enterica serovar Enteritidis, the most common cause of human gastroenteritis, employs several virulence factors including lipopolysaccharide (LPS) for infection and establishment of disease inside the host. The LPS of S. enterica serovar Enteritidis consists of lipid A, core oligosaccharide and O-antigen (OAg). The OAg consists of repeating units containing different sugars. The sugars of OAg are synthesized and assembled by a set of enzymes encoded by genes organized into clusters. Present study focuses on the effect of deletion of genes involved in biosynthesis of OAg repeating units on resistance to antimicrobial peptides and virulence in mice. In the present study, the OAg biosynthesis was impaired by deleting tyv, prt and wbaV genes involved in tyvelose biosynthesis and its transfer to OAg. The virulence phenotype of resulting mutants was evaluated by assessing resistance to antimicrobial peptides, serum complement, adhesion, invasion and in vivo colonization. Deletion of the above three genes resulted in the production of OAg-negative LPS. All the OAg-negative mutants showed phenotype reported for rough strains. Interestingly, ΔwbaV mutant showed increased resistance against antimicrobial peptides and normal human serum. In addition, the ΔwbaV mutant also showed increased adhesion and invasion as compared to the other two O-Ag negative mutants Δtyv and Δprt. In vivo experiments also confirmed the increased virulent phenotype of ΔwbaV mutant as compared to Δprt mutant. OAg-negative mutants are known to be avirulent; however, this study demonstrates that certain OAg negative mutants e.g. ∆wbaV may also show resistance to antimicrobial peptides and cause colitis in Streptomyces pretreated mouse model.

23 April 2021 in Transactions of the Royal Society of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
PDF file
BDBidyut Kumar Das
Bidyut Kumar Das
SMSriprasad Mohanty
Sriprasad Mohanty
PSPrakash Kumar Sahoo
Prakash Kumar Sahoo
Background: Acute encephalitis syndrome (AES) is a major public health concern in India, causing febrile illness principally associated with viral infection. Bacteria-like scrub typhus and leptospirosis also cause acute febrile illness. Therefore, this study was conceived to address the possible etiological agents contributing to sporadic AES in a tertiary care center in Odisha, India. Method: This was a prospective hospital-based study that enrolled 92 consecutive patients with clinically diagnosed AES whose blood/cerebrospinal fluid samples were tested for IgM antibodies to dengue, Japanese encephalitis (JE), herpes simplex virus (HSV), Epstein-Barr virus (EBV), leptospirosis and scrub typhus. Results: Viral antibodies to dengue were detected in three (3.26%) cases, HSV1 in four (4.34%) and HSV2 in three (3.26%) cases. Significantly, antibodies to EBV in 22 (23.591%) and to JE in 27 (29.34%) cases were detected. Notably, 30 (32.60%) and 11(12.0%) of patients had IgM antibodies to leptospirosis and scrub typhus, respectively. Conclusion: This observation indicates an association of leptospirosis and scrub typhus infection in sporadic cases of AES, besides other viruses.

10 July 2013 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
MPMadhumita Panda
Madhumita Panda
PSPrakash Kumar Sahoo
Prakash Kumar Sahoo
AMAlok Das Mohapatra
Alok Das Mohapatra
SDSoumya Kanti Dutta
Soumya Kanti Dutta
PTPravat K Thatoi
Pravat K Thatoi
BRBalachandran Ravindran
Balachandran Ravindran
Enhanced inflammatory host responses have been attributed as the cellular basis for development of severe malaria as well as sepsis. In contrast to this, filarial infections have been consistently reported to be associated with an immunological hypo-responsive phenotype. This suggests that successful control of filariasis by employing mass drug administration, could potentially contribute to an increase in incidence of sepsis and cerebral malaria in human communities. A case control study was undertaken to address this critical and urgent issue.

1 June 1994 in Parasite Immunology
Verified
Journal Article
Closed access
PDF file
BRBalaraman Ravindran
Balaraman Ravindran
ASA. K. Satapathy
A. K. Satapathy
PSPrakash Kumar Sahoo
Prakash Kumar Sahoo

30 June 2022 in Tropical Doctor
Verified
Journal Article
Closed access
ASAbhinav Sinha
Abhinav Sinha
SMSumegha Mohapatra
Sumegha Mohapatra
SMShubhashisha Mohanty
Shubhashisha Mohanty
SPSanghamitra Pati
Sanghamitra Pati
PSPrakash Kumar Sahoo
Prakash Kumar Sahoo
Sustainable Development Goal-3 (SDG) aims to eliminate lymphatic filariasis by 2030 through >65% coverage and compliance of mass drug administration (MDA), the preventive chemotherapy strategy of delivering anthelminthic drugs. However, the ongoing COVID-19 pandemic has disrupted such programmes, yet MDA was administered during February 2021 in Odisha, India. We aimed to assess the coverage and compliance of the present round of MDA amidst the pandemic and explore factors for non-compliance in Cuttack district of Odisha, a filariasis endemic area. Community-based participants enrolled through multistage stratified sampling were administered a semi-structured questionnaire following COVID-19 protocols. The coverage of MDA was 93.2% whereas consumption was 73.7%. Participants reported that healthcare workers were motivated and satisfactorily explained the benefits of MDA but still fear of side-effects was the major cause of non-compliance. Nonetheless, this recent round of MDA was effective, despite challenges posed by the ongoing pandemic.